20/20 BIOLABS, INC. Earnings Per Share (Diluted)
20/20 BIOLABS, INC. (AIDX) reported Earnings Per Share (Diluted) of -$0.26 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- 20/20 BIOLABS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.26.
- 20/20 BIOLABS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.28.
- 20/20 BIOLABS, INC. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.17.
- 20/20 BIOLABS, INC. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.16.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|
| 2026-06-30 | -$0.26 10-Q · filed 2026-08-14 | -$0.54 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$0.28 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | -$0.76 POS AM · filed 2026-04-06 | ||
| 2025-06-30 | -$0.17 10-Q · filed 2026-08-14 | -$0.33 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$0.16 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | -$1.16 POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |